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Abstract
Background: Uterine smooth muscle cells exhibit ionic currents that appear to be important in
the control of uterine contractility, but how these currents might produce the changes in
contractile activity seen in pregnant myometrium has not been established. There are conflicting
reports concerning the role of voltage-gated potassium (Kv) channels and large-conductance,
calcium-activated potassium (BK) channels in the regulation of uterine contractility. In this study
we provide molecular and functional evidence for a role for Kv channels in the regulation of
spontaneous contractile activity in mouse myometrium, and also demonstrate a change in Kv
channel regulation of contractility in pregnant mouse myometrium.
Methods: Functional assays which evaluated the effects of channel blockers and various contractile
agonists were accomplished by quantifying contractility of isolated uterine smooth muscle obtained
from nonpregnant mice as well as mice at various stages of pregnancy. Expression of Kv channel
proteins in isolated uterine smooth muscle was evaluated by Western blots.
Results: The Kv channel blocker 4-aminopyridine (4-AP) caused contractions in nonpregnant
mouse myometrium (EC50 = 54 micromolar, maximal effect at 300 micromolar) but this effect
disappeared in pregnant mice; similarly, the Kv4.2/Kv4.3 blocker phrixotoxin-2 caused contractions
in nonpregnant, but not pregnant, myometrium. Contractile responses to 4-AP were not
dependent upon nerves, as neither tetrodotoxin nor storage of tissues at room temperature
significantly altered these responses, nor were responses dependent upon the presence of the
endometrium. Spontaneous contractions and contractions in response to 4-AP did not appear to
be mediated by BK, as the BK channel-selective blockers iberiotoxin, verruculogen, or
tetraethylammonium failed to affect either spontaneous contractions or 4-AP-elicited responses.
A number of different Kv channel alpha subunit proteins were found in isolated myometrium from
both nonpregnant and term-pregnant mice, and one of these proteins – Kv4.3 – was found to
disappear in term-pregnant tissues.
Conclusion: These findings suggest a role for Kv channels in the regulation of uterine contractility,
and that changes in the expression and/or function of specific Kv channels may account for the
functional changes seen in pregnant myometrium.
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Background
The smooth muscle of the uterus changes remarkably dur-
ing pregnancy. Despite the presence of spontaneous, myo-
genic contractility, the myometrium must remain
quiescent as it is stretched to an extraordinary degree dur-
ing pregnancy, but suddenly develop the highly organized
and powerful contractions characteristic of labour. Myo-
metrial cells in pregnant animals express increased densi-
ties of oxytocin receptors and gap junctions which are
known to play important roles in uterine contraction[1];
these changes appear to be essential but not sufficient for
the onset of labouring contractions. The signals which
trigger labour are not known. Our overall goal is to deter-
mine the changes in fundamental properties which must
occur in uterine smooth muscle cells during the transition
into labour.
The biochemical mechanisms associated with contraction
in the myometrium are reasonably well understood.
There is also a great deal of evidence that changes in ionic
conductances across the plasma membrane are involved
in the regulation of spontaneous and agonist-evoked con-
tractions in uterine myocytes from both pregnant and
nonpregnant animals [2-4]. Spontaneous contractions in
uterine myocytes are associated with and probably arise
from gradual depolarisations of resting membrane poten-
tial [3], and there is evidence that maximum resting mem-
brane potentials decrease in uterine smooth muscle cells
in women and rats during the course of pregnancy [5-7].
However, our understanding of the roles played by spe-
cific ion currents in the regulation of contractile activity is
poor, and the molecular identity of the channels which
underlie these currents is in most cases not known.
Changes in electrical currents in uterine myocytes may be
important points of regulation of contractility in the tran-
sition between the quiescent and labouring uterus at the
end of gestation [2,3].
Action potentials in uterine myocytes result from activa-
tion of voltage-operated calcium channels; membrane
depolarisations are halted and reversed by the inactiva-
tion of these channels as well as the concurrent activation
of outward currents carried by potassium ions [8,9]. Sev-
eral types of potassium channels are known to be present
in myometrium, including the large-conductance, cal-
cium-activated potassium (BK) channel [10,11], the ATP-
sensitive potassium (KATP) channel [12,13], and at least
one inward rectifier [14]. There is also some evidence for
potassium currents in myometrium which are voltage
gated [15], including evidence for the presence of Kv
channels which are assumed to consist of multimers of α
subunits which are known to form the pore region of
these voltage-gated channels [16-19,16]. [19,20]. Large-
conductance, calcium-activated potassium channels have
been shown to be involved in the repolarisation of cell
membranes during action potentials. In uterine smooth
muscle cells the currents responsible for setting resting
membrane potential – a key component of regulation of
activity in other excitable cells – are not known. It has
been suggested that BK, at least in human myometrium, is
the current responsible for regulating electrical (and thus
contractile) activity [10], but experiments performed
upon rat myometrium have produced contradictory find-
ings which argue against a role for BK in the regulation of
contractility in either pregnant or nonpregnant myo-
metrium[21].
We now describe a large contractile response to the Kv
channel-selective blocker 4-aminopyridine (4-AP) in
myometrium; this response is not mediated by BK chan-
nels, the endometrium, or nerves. We also demonstrate
the expression in both nonpregnant and pregnant mouse
myometrium of a number of Kv channel α subunit pro-
teins, including several types known to be sensitive to 4-
AP. Remarkably, contractile responses to 4-AP disappear
in pregnant mouse myometrium, and this finding is cor-
related with the loss in expression of the Kv4.3 α subunit
protein. The presence of a contractile response to 4-AP as
well as a number of Kv channel α subunit proteins in
mouse myometrium suggests a role for Kv channels in the
regulation of myometrial function. Furthermore, the dis-
appearance of Kv4.3 expression and of responses to 4-AP
and phrixotoxin-2 in pregnant myometrium may indicate
a specific loss of Kv channel function at the point when
the myometrium is being prepared for labour.
Methods
Preparation of uterine tissues and contraction 
experiments
Contractile studies were performed on uterine tissues
obtained from virgin 8–25 week-old or timed (7–20 days
following a single 12 hour caging with a proven male)
pregnant mice, with term-pregnancy being defined as day
20 of gestation (P20); female mice were of the C57BL/6J
strain (Jackson Laboratories, Bar Harbor, ME), but males
were CF-1 mice obtained from Charles River Laboratories,
Wilmington, MA. Animals were sacrificed by cervical dis-
location according to protocols approved by the
Creighton Institutional Review Board; uterine horns were
removed and immediately placed into ice-cold contrac-
tion buffer consisting of the following (in mM): NaCl,
120; KCl, 5.0; KH2PO4, 0.59; Na2HPO4, 0.60; MgCl2, 2.6;
dextrose, 20.0; tris (hydroxymethyl) amino-methane,
25.0; CaCl2, 1.8. Uterine horns were opened by cutting
along the mesometrial border while immersed in ice-cold
oxygenated buffer, pinned serosal-side down on a bed of
Sylgard® (Dow Corning, Midland, MI) and strips approxi-
mately 10 mm × 5 mm × 2 mm of full-thickness
(endometrium plus myometrium) uterine tissue were
sliced from the centre of the horn with the long axis of theReproductive Biology and Endocrinology 2007, 5:41 http://www.rbej.com/content/5/1/41
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strip parallel to the long axis of the horn in situ. In experi-
ments utilizing isolated (endometrium-free) myo-
metrium, a small incision was made through the
endometrium at one end of each horn and the
endometrium was carefully peeled away from the under-
lying smooth muscle layers by the use of fine-tipped for-
ceps; both outer longitudinal and inner circular muscle
layers remained in these preparations, and each of these
layers was found to consist of cells approximately 20 lay-
ers thick. Tissue strips were attached to TRN 20 g isometric
force transducers (Kent Scientific, Litchfield, CT) by silk
thread in 20 ml water-jacketed organ baths to favour
recording from the longitudinal muscle layer; transducer
voltages were amplified and converted to digital signals by
an ACJr® A/D board mounted within a computer system
running the Workbench® data acquisition system (Straw-
berry Tree, Inc., Sunnyvale, CA). Strips were maintained at
37°C with constant aeration with 100% O2. Tissues were
loaded with an initial tension of 0.25 grams and chal-
lenged with maximal concentrations of acetylcholine
(100 µM) or oxytocin (1 µM) during the course of a 30–
60 minute equilibration period. In experiments in which
the Kv4.2/Kv4.3 blocker phrixotoxin-2 was used, a spe-
cially-designed and -built micro organ bath assembly was
used so that tissues could be mounted in very small (200
µL), vertically-oriented chambers milled out of cast acrylic
in order to reduce the amount of phrixitoxin-2 required;
in this apparatus tissues were constantly superfused with
warm, oxygenated contraction buffer.
Noncumulative concentration-response relationships
were developed in a manner which allowed each tissue
strip to serve as its own control. Spontaneous contractile
activity for 5 minutes immediately preceding each drug
challenge was quantified and subtracted from values
obtained from subsequent 5 minute drug challenges in
order to control for differences in spontaneous contractile
activity among different tissue strips, and to control for
changes in spontaneous contractility that might occur
during the course of each experiment. Pretreatment of tis-
sues with maximal concentrations of toxins was per-
formed for a minimum of 10 minutes. Tissues were
allowed to relax for at least 10 minutes after each agonist
stimulation, during which tensions returned to baseline
values. Addition of 4-AP at the highest concentrations
used did not alter the pH of the solution in the organ
baths. Dimethylsulfoxide was the solvent for verruculo-
gen and did not reach concentrations in organ baths
higher than 0.01% by volume; all other solutions were
created using contraction buffer as the solvent.
Data analysis
Contractile responses were quantified by integration of
the area underneath the contractile record by software
specifically written for this purpose. Spontaneous contrac-
tile activity was quantified and subtracted from all drug-
elicited responses. Unless stated otherwise, values for
force of contraction are expressed as mg tension gener-
ated, ± one standard error of the mean (S.E.M.). Popula-
tion sample numbers (n) indicate the number of animals
used, and not simply number of tissues. Comparison of
mean responses to maximal concentrations of 4-AP were
compared for all time points by means of a one-way
ANOVA followed by Tukey's post-hoc test.
Western blotting
Samples of isolated, endometrium-free uterine smooth
muscle (approx. 500 mg/sample) were placed into a 1×
sample buffer consisting of 125 mM Tris-HCl, 2% SDS,
5% glycerol, 0.003% bromophenol blue, and 1% 2-mer-
captoethanol; samples were homogenized using a Duall®
glass-glass tissue grinder until completely disrupted. After
heating samples for 5 minutes at 95°C, precipitates were
removed by centrifugation. Separation of proteins was
performed by means of loading polyacrylamide gels con-
taining 8% acrylamide and stacking gels made to contain
4.75% acrylamide with 20 µg of protein in each lane;
these gels were built using a BioRad® mini-gel apparatus in
order to accomplish protein separations within 1 hour at
a constant voltage of 200 V. High-range, pre-stained
molecular weight markers were used to provide an indica-
tion of apparent molecular weights following transfer
onto polyvinylidene fluoride (PVDF) membranes. Fol-
lowing separations, gels were immediately used as donors
for transfer of proteins to PVDF membranes by means of
a semi-dry transfer apparatus; at room temperature this
procedure took 90 minutes at a constant current of 0.8
mA/cm2. Membranes were blocked with 5% (w/v) nonfat
milk plus 0.05% Tween 20 and sodium azide at 0.02%
(w/v) in Tris-saline solution containing 150 mM NaCl
and 10 mM tris (hydroxymethyl) amino-methane at 4°C
overnight with rocking. Incubations with primary anti-
bodies (all purchased from Alomone Labs, Jerusalem:
Kv1.1 (cat. #AN-03), Kv1.2 (cat. #AN-04), Kv1.3 (cat.
#AN-03), Kv1.4 (cat. #AN-06), Kv1.5 (cat. #AN-04),
Kv1.6 (cat. #AN-03), Kv4.2 (cat. #AN-04) and Kv4.3 (cat.
#AN-04)) at dilutions of 1:200-500 were performed in
Tris-saline solution containing nonfat milk at 0.05% (w/
v), Tween 20 at 0.05% (v/v) and sodium azide at 0.02%
(w/v) for 1.5 hours at room temperature with rocking.
After extensive washing, membranes were incubated with
secondary antibody (goat anti-rabbit, 1:15,000, Southern
Biotech) in a Tris-saline solution containing nonfat milk
at 0.05% (w/v) and Tween 20 at 0.05% for 1.5 hours at
room temperature. Secondary antibodies were conjugated
to horseradish peroxidase; following washing of mem-
branes, light-generating reactions were initiated by incu-
bation of filters in a solution containing ECL® reagent
(Pharmacia) and filters were exposed to X-ray films. Band
densities were quantified by means of the Molecular Ana-Reproductive Biology and Endocrinology 2007, 5:41 http://www.rbej.com/content/5/1/41
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lyst® program, normalized to the darkest band present on
each film, and compared by one-way ANOVA.
Results
4-AP contracts nonpregnant myometrium
Mouse myometrium exhibited both spontaneous and
agonist-elicited contractions in vitro. Contractile responses
to 4-AP in nonpregnant samples were characterized by an
increase in baseline tension and an increase in the fre-
quency of phasic activity (Figure 1.a), and responses to
maximal concentrations of 4-AP were smaller than those
seen in response to maximal concentrations of either ace-
tylcholine or oxytocin. Upon washout of contractile
agents, tissue activities resembled those present immedi-
ately prior to agonist addition, and no cumulative effects
of drug treatment were observed during the course of
experiments. Nerves were not involved in contractile
responses to 4-AP, as incubation of tissues with the volt-
age-activated sodium channel blocker tetrodotoxin (1
µM, 15 minutes) had no significant effect (Figure 1.b),
4-AP contracts the nonpregnant (NP) mouse myometrium Figure 1
4-AP contracts the nonpregnant (NP) mouse myometrium. (A) Representative contractile recording of the response 
to 4-AP in nonpregnant mouse myometrium. Horizontal component of arrows denotes duration of 4-AP incubation. (B) Pre-
treatment (15 min) of nonpregnant myometrial tissue strips with 1 µM tetrodotoxin (TTX) failed to alter the contractile 
response to 4-AP (n = 4). (C) Concentration-response relationships of full-thickness tissue strips (filled circles, n = 5) and iso-
lated, endometrium-free myometrium (open circles, n = 4); data are responses in nonpregnant mice expressed as a mean per-
centage (± S.E.M.) of the maximal response elicited by 4-AP in each tissue strip, minus the spontaneous activity immediately 
preceding each addition of 4-AP.Reproductive Biology and Endocrinology 2007, 5:41 http://www.rbej.com/content/5/1/41
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and responses to 4-AP were not significantly altered by
storage of either full-thickness tissues or isolated myo-
metrium at room temperature for 18 hours (data not
shown), during which it is assumed that severed nerves
remaining in the preparations would have lost their abil-
ity to function. The endometrium was not required for 4-
AP-elicited contractions in nonpregnant myometrium, as
a comparison of concentration-response curves between
full-thickness tissue strips and isolated myometrium
(endometrium removed) revealed no significant differ-
ences in 4-AP potency (EC50 ≈ 54 µM) or efficacy (Figure
1.c).
Lack of a role for BK in either spontaneous- or 4-AP-
elicited contractions
Addition of the BK blocker tetraethylammonium (TEA) at
concentrations as high as 1 mM to spontaneously-active
myometrium had no effect on either the frequency or
amplitude of spontaneous contractions (not shown), nor
did it affect the total amount of tension generated by these
tissues (Figure 2.a). Contractile responses to 4-AP were
also not mediated by BK channels, as treatment of tissues
with maximal concentrations of either of the BK channel
blockers iberiotoxin or verruculogen had no effect upon
subsequent responses to 4-AP (Figure 2.b, c); neither ibe-
riotoxin nor verruculogen had any effects on spontaneous
activity alone (i.e., when added during the preincubation
periods, data not shown). As indicated in the legend to
Figure 2, spontaneous activity has been mathematically
removed from the values indicating responses to 4-AP in
panels B and C so as to avoid any contribution of chang-
ing spontaneous activity levels to the assessment of the
effects of either 4-AP or blockers of BK.
Loss of 4-AP-induced contractions in pregnancy
4-Aminopyridine, while capable of eliciting contractions
in nonpregnant myometrium at relatively low concentra-
tions, did not contract myometrium obtained from term-
pregnant mice (Figure 3.b, left-most recording) even
when present at concentrations as high as 1 mM (Figure 4,
open circles); term-pregnant tissues remained, however,
fully responsive to acetylcholine or oxytocin (Figure 3.b).
Expression of Kv channel proteins
Because 4-AP is a well-known blocker of Kv channels, we
sought to determine whether any Kv channel proteins are
present in mouse myometrium. Several types of Kv chan-
nel α subunit proteins were found to be expressed in iso-
lated, endometrium-free uterine smooth muscle from
both pregnant and nonpregnant mice (Figure 5). No con-
sistent differences in expression between nonpregnant
and term-pregnant tissues were seen for Kv1.1, Kv1.2,
Kv1.3, Kv1.4, Kv1.5, Kv1.6, or Kv4.2. However, while
Kv4.3 was expressed at relatively high levels in nonpreg-
nant myometrium, we were essentially unable to detect
Large-conductance, calcium-activated potassium channel is  not involved in either the 4-AP response or spontaneous  activity in nonpregnant mouse myometrium Figure 2
Large-conductance, calcium-activated potassium 
channel is not involved in either the 4-AP response or 
spontaneous activity in nonpregnant mouse myo-
metrium. (A) Tissue strips from nonpregnant mice were 
challenged with 1 mM of the BK blocker TEA. There were no 
significant differences found between tissue strip contractility 
in the presence of TEA when compared to spontaneous (no 
TEA) activity. (B and C) Tissue strips from nonpregnant mice 
were challenged with 300 µM 4-AP for 5 min, washed for 10 
minutes, and then incubated with either iberiotoxin (IbTX, 
50 nM, panel B) or verruculogen (100 nM, panel C) for 10 
minutes prior to re-challenge with 300 µM 4-AP; the amount 
of spontaneous contractile activity present in each sample 
was subtracted from the total activity seen in the presence of 
either 4-AP or 4-AP plus BK blocker to account for any 
changes in spontaneous activity. Mean responses in the pres-
ence of toxin (A and B) or TEA (C) were not significantly dif-
ferent from those seen in the absence of either toxin or TEA. 
Results are presented as means ± S.D.; n = 4 for each panel.
Figure 2Reproductive Biology and Endocrinology 2007, 5:41 http://www.rbej.com/content/5/1/41
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this protein by Western blot in myometrial samples from
term-pregnant mice (Figure 5, bottom panel).
Loss of Kv4.2/Kv4.3 responses in pregnancy
In an attempt to correlate the loss of 4-AP responses with
the loss of Kv4.3 expression in pregnant myometrium, we
used the Kv4.2/Kv4.3-specific blocker phrixotoxin-2 in
contraction experiments on both nonpregnant and term-
pregnant tissues. After determining the concentration at
which phrixotoxin-2 elicits a maximal contraction in
mouse myometrium (700 nM, data not shown), we found
that while phrixotoxin-2 consistently elicited contractile
responses in nonpregnant tissues which were character-
ized by an increase in baseline tension without any signif-
icant increase in frequency of contractions (Figure 6.a), it
failed to produce contractions in tissues from term-preg-
nant mice (Figure 6.b) even when used at concentrations
as high as 1.3 µM; phrixotoxin-2 effects were not observed
Disappearance of 4-AP responses in pregnant mouse myometrium Figure 3
Disappearance of 4-AP responses in pregnant mouse myometrium. Representative contractile recordings are from 
nonpregnant (panel A) and term-pregnant (P20) mouse myometrium (panel B). Horizontal component of arrows denotes 
duration of each drug incubation. All 3 recordings in each panel were obtained from the same tissue strip and are representa-
tive of results obtained from 5 nonpregnant and 5 term-pregnant mice. Panel A: Contractile responses to maximal concentra-
tions of 4-AP, acetylcholine (Ach), and oxytocin (OT) in nonpregnant mouse myometrium. Panel B: Contractile responses to 
Ach and OT are shown in contrast to the absence of a contractile response to 300 µM 4-AP in term-pregnant mouse myo-
metrium.
Figure 3Reproductive Biology and Endocrinology 2007, 5:41 http://www.rbej.com/content/5/1/41
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in pregnant tissues from any stage (P7 through term), and
therefore roughly paralleled those seen in response to 4-
AP in nonpregnant and pregnant myometrium (see Figure
7). Phrixotoxin-2-elicited contractions in nonpregnant
myometrium were on average significantly smaller than
those seen in response to 4-AP; this finding leads us to
suggest that phrixotoxin-2 may be blocking only a small
amount of total outward (potassium) current, and that it
is therefore capable of eliciting only a small depolarisa-
tion (and consequently contraction) in uterine smooth
muscle cells.
Kv4.3 expression, 4-AP-induced contraction time courses
By means of contraction experiments performed on tis-
sues taken from animals at various stages of pregnancy
(P7, P10, P15, and P20) we were able to establish time
courses of the loss of both 4-AP responsiveness and Kv4.3
expression. At the earliest gestational point examined (P7)
contractile responses to 4-AP were reduced compared to
those seen in nonpregnant tissues (Figure 7.a), and at 300
µM 4-AP (the concentration at which contractile
responses become maximal in nonpregnant myo-
metrium), mean contractile responses to 4-AP in samples
taken from mice from each stage of gestation (P7, P10,
P15, and P20) were significantly reduced compared to
those found in nonpregnant samples (Figure 7.a). Com-
parison by densitometry revealed a significant (p = 0.01)
reduction in Kv4.3 band densities in term-pregnant (P20)
Kv channel α subunit proteins are expressed in mouse myo- metrium Figure 5
Kv channel α subunit proteins are expressed in 
mouse myometrium. Results obtained from Western 
blots demonstrating the presence of immunoreactive bands 
for Kv1.1, Kv1.2, Kv1.3, Kv1.4, Kv1.5, Kv1.6, and Kv4.2 α-
subunits in myometrium from nonpregnant (NP) and term-
pregnant (P20) mice. Kv4.3 α-subunits were detected in the 
NP samples, but were undetectable in the term-pregnant 
mouse myometrium. Apparent molecular weights of each 
protein species are indicated at right. Different lanes contain 
samples from different animals, and each lane was loaded 
with 20 µg protein; 4–7 animals were assayed for each Kv 
channel α subunit protein.
4-Aminopyridine concentration-response relationships in  nonpregnant (NP) and term-pregnant (P20) mouse myo- metrium Figure 4
4-Aminopyridine concentration-response relation-
ships in nonpregnant (NP) and term-pregnant (P20) 
mouse myometrium. Non-cumulative additions of 4-AP 
at concentrations above 10 µM produced contractions in 
nonpregnant tissues (filled circles, n = 5) but not in term-
pregnant tissues (open circles, n = 5). Results are presented 
as the mean percentage of the maximal response to 4-AP in 
nonpregnant tissue strips, ± S.E.M.Reproductive Biology and Endocrinology 2007, 5:41 http://www.rbej.com/content/5/1/41
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vs. either nonpregnant or P7 through P15 animals (Figure
7.b). The time course of changes in Kv4.3 expression was
different from the time course of changes in 4-AP
responses, as expression of Kv4.3 in mouse myometrium
was significantly reduced only after the 15th day of preg-
nancy (Figure 7.b). While there was variability in the level
of expression of Kv4.3 at different stages of pregnancy,
expression of Kv1.4 was found to be highly consistent
throughout the stages of pregnancy and from experiment
to experiment (Figure 7.b). Visceral smooth muscle (γ)
actin expression was relatively constant until P20, at
which point its expression was significantly increased, a
finding which strongly supports those reported by Shyn-
lova et al. [22].
Discussion
In this study we demonstrate that the Kv channel blocker
4-AP potently contracts the mouse myometrium, and that
it does so by a nerve- and endometrium-independent
mechanism. Contractions elicited by 4-AP did not require
functioning BK channels, and we found no evidence for a
role for BK in the regulation of spontaneous contractility
in either nonpregnant (Figure 2) or pregnant (data not
shown) mouse myometrium. Remarkably, contractile
responses to 4-AP disappear in pregnant mouse myo-
metrium, to the point where 4-AP is unable to elicit any
contraction at all in late pregnancy. A number of types of
Kv channel α subunit proteins were found to be expressed
in both pregnant and nonpregnant mouse myometrium,
and one of these – Kv4.3 – was found to disappear from
the mouse myometrium by the end of gestation, as was
the contractile response to the Kv4.2/Kv4.3-specific
blocker phrixotoxin-2. These data are consistent with the
hypothesis that 4-AP contracts nonpregnant mouse myo-
metrium by blocking Kv4.2 and/or Kv4.3, and that the
disappearance of Kv4.3 in pregnancy accounts for the
observed loss in 4-AP responses in this tissue.
Contractions in nonpregnant mouse myometrium
occurred in response to surprisingly low concentrations of
4-AP (compared to those required to elicit contraction in
other smooth muscles[17]), a finding perhaps best
explained by the large number of different Kv channel
subtypes we now report to be present in myometrium
from both nonpregnant and term-pregnant mice (see Fig-
ure 5) including several types (e.g. Kv1.4, Kv4.2, and
Kv4.3) known from the work of others to be sensitive to
4-AP [23]. Contractions in response to 4-AP have been
shown to occur in a variety of non-uterine smooth mus-
cles, including those found in the vasculature [24,25]. and
gastrointestinal system [26-29]. In rat myometrium, 4-AP
has recently been found to cause contractions in nonpreg-
nant and, in contrast to our present findings in mouse,
pregnant myometrium [21], although the concentrations
of 4-AP employed in the rat experiments were signifi-
cantly higher than those used in the present study. Mech-
Phrixotoxin-2 (PhTx) contracts the nonpregnant but not the term-pregnant myometrium Figure 6
Phrixotoxin-2 (PhTx) contracts the nonpregnant but not the term-pregnant myometrium. Representative con-
tractile recordings are from nonpregnant (panel A) and term-pregnant (panel B) mouse myometrial tissue strips. Horizontal 
component of arrows denotes duration of each drug incubation.Reproductive Biology and Endocrinology 2007, 5:41 http://www.rbej.com/content/5/1/41
Page 9 of 12
(page number not for citation purposes)
anistically, 4-AP is thought to cause smooth muscle
contraction by blocking one or more members of the Kv
channel family, something 4-AP has long been known to
be capable of doing in non-muscle cells [17]. 4-Aminopy-
ridine has been shown to depolarise rat myometrium
[30], and we assume that contractions elicited by 4-AP in
myometrium are associated with membrane depolarisa-
tions as well.
In an effort to narrow our search for the molecular tar-
get(s) for 4-AP in myometrium we have been able to rule
out several possibilities, including nerves, the
endometrium, and BK channels. With respect to the latter,
there appears to be a relatively high level of BK channel
expression in myometrium in a number of species [11],
and the expression of BK may be regulated by the hormo-
nal environment and/or reproductive state of the animal
[31]. A role for BK channels in the repolarisation of uter-
ine myocyte membranes has been well-established
[10,11,32]. It has also been suggested that BK channels
may regulate the resting membrane potential of (and
therefore the spontaneous contractile activity in) human
and rat uterine myocytes [10]; as mentioned earlier, we
have found no evidence of a role for BK channels in the
regulation of spontaneous contractility in mouse myo-
metrium, as we have found no effect of BK blockers such
as TEA, verruculogen, or iberiotoxin on spontaneous con-
tractility in myometrium from either pregnant or non-
pregnant mice. In this our work supports that of Aaronson
et al. [21], who argue that BK does not play a role in the
regulation of contractility in the rat myometrium, and
that one or more Kv channels are instead responsible for
this regulation[21]. Since we now find that contractile
responses to 4-AP in nonpregnant mouse myometrium
(Figure 4) occur at concentrations significantly below
those thought necessary to block BK channels in other tis-
sues [17], and that pretreatment of nonpregnant mouse
myometrium with concentrations of iberiotoxin or ver-
ruculogen which should be effective at blocking BK chan-
nels [33,34] had no effect upon subsequent contractile
responses to 4-AP (Figure 2), we do not believe that 4-AP
is contracting mouse myometrium by blocking BK chan-
nels. It therefore appears that the mechanism by which
resting membrane potential in myometrial cells is set has
yet to be determined.
The relatively high potency of 4-AP in nonpregnant
mouse myometrium, coupled with our finding of the
expression of a number of 4-AP-sensitive Kv channel α
subunit proteins, suggests the blockade of Kv channels as
a possible mechanism for 4-AP-elicited contractions in
this tissue. While Kv channels are thought to be primarily
responsible for limiting and reversing membrane depo-
larisation during the action potential [17,35], there is evi-
dence that Kv channels can regulate resting membrane
potential of smooth muscle cells in pulmonary artery [36-
38], coronary artery [25], and airways [39]. There is, how-
ever, little evidence that Kv channels are active (and there-
Time course of loss of 4-AP responsiveness and Kv4.3  expression in pregnant mouse myometrium Figure 7
Time course of loss of 4-AP responsiveness and Kv4.3 
expression in pregnant mouse myometrium. Myome-
trial samples were obtained from nonpregnant (NP, n = 5), 7 
days pregnant (P7, n = 3), 10 days pregnant (P10, n = 3), 15 
days pregnant (P15, n = 4) and term-pregnant (P20, n = 5) 
mice. Panel A: Results from non-cumulative concentration-
response experiments are presented as mean percentages of 
the maximal response to 4-AP in NP tissues. Panel B: Densit-
ometry of Kv4.3 expression in the same samples evaluated in 
panel (A) and typical Western blot results demonstrating 
expression of Kv4.3 as well as Kv1.4 and γ-actin to confirm 
equal protein loading. Band densities are expressed in graph 
as a percentage of the maximal band density on each film; 
asterisks denote a significant difference (P = 0.01) between 
average NP and term-pregnant sample band densities.Reproductive Biology and Endocrinology 2007, 5:41 http://www.rbej.com/content/5/1/41
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fore available for blockade) at membrane potentials such
as those found in resting, nonpregnant myometrium (-55
mV). However, a unique electrical property of myo-
metrium may explain how Kv channels could regulate
resting membrane potential in this tissue. Myometrium is
apparently alone among smooth muscles in expressing a
transient outward (A-type) current with a threshold of
activation that is equal if not negative to the resting mem-
brane potential [40,41]; this A-type current is known, in
many cases, to be conducted by 4-AP-sensitive Kv chan-
nels, including Kv4.3. It is possible that the myometrium
expresses a unique complement of Kv channels with dis-
tinctive biophysical properties that result in a 4-AP-sensi-
tive current which is active at rest and therefore available
for blockade by 4-AP. Interestingly, it is also known that a
4-AP-sensitive, A-type current present in nonpregnant rat
myometrium disappears during pregnancy [19]; it may be
the loss of this current which renders the term-pregnant
mouse myometrium insensitive to 4-AP, as shown in the
present work. It is also possible that the loss in A-type cur-
rent expression accounts for the gradual movement of
resting membrane potential to more positive values which
is known to occur in the myometrium of women and rats
during pregnancy [3].
We demonstrate the expression in mouse myometrium of
a number of α subunit proteins belonging to the Kv family
of potassium channels. While our preparations are highly
enriched for uterine smooth muscle, we cannot rule out a
minor contribution by nervous or vascular tissues to our
findings of Kv channel α subunit proteins; histological
examination of our preparations of uterine smooth mus-
cle demonstrates, however, that the vast majority (> 95%)
of the cells present in our preparations are uterine smooth
muscle cells (data not shown), and thus the proteins
present in our Western blot figures almost certainly reflect
primarily the expression of proteins in these predominant
(visceral smooth muscle) cell types. While there appear to
be slight differences in the expression levels of some of the
Kv channel α subunits shown in Figure 5 (e.g. there
appears to be a little more Kv1.1 expression in term-preg-
nant myometrium than in nonpregnant tissues), we are
unwilling at present to ascribe any significance to these
differences other than the profound reduction in Kv4.3
expression which occurs near the end of gestation (Figures
5 and 7), a finding which is consistent with those of Song
et al. [19] who found a reduction in Kv4.3 mRNA and pro-
tein expression in pregnant rat uterus which appears to be
dependent upon estrogen.
We do not know with certainty that 4-AP causes contrac-
tions in nonpregnant mouse myometrium by blocking Kv
channels, nor can we claim that the disappearance of
Kv4.3 channels at the end of pregnancy is clearly respon-
sible for the loss of 4-AP responsiveness seen in these tis-
sues. However, our contraction studies with phrixotoxin-
2 suggest that Kv4.2 and/or Kv4.3 could well be molecular
targets for 4-AP in mouse myometrium, and since both
phrixotoxin-2- and 4-AP-elicited contractions disappear
in pregnant myometrium, we suggest that changes in
Kv4.3 expression may result in functional changes in
term-pregnant myometrium, with 4-AP responsiveness
being at the very least an indicator of these changes. These
observations are consistent with the hypothesis that the
pregnant myometrium is by default a highly contractile
organ, and that it is only the presence of a large amount of
outward (polarising) potassium current that maintains
the myometrium in a quiescent state until it is time for
labour to begin; myometrium possesses, after all, a strong
myogenic response to stretch, and certainly the uterus
stretches to a remarkable degree in order to accommodate
the developing foetus during pregnancy. Our functional
and molecular results suggest that the disappearance of
specific Kv channels (such as Kv4.3) may be responsible
for a loss of outward (relaxing) potassium current and
consequently the increase in contractility characteristic of
labour.
Examination of the data contained within Figure 7 reveals
a difference between the time courses of reductions in
Kv4.3 expression and 4-AP responsiveness, with the loss
of 4-AP responsiveness preceding the reduction in Kv4.3
expression in pregnant mouse myometrium by at least 2
weeks. Given that Kv channels are known to form hetero-
multimers of α and β subunits (as well as combine with
various accessory proteins specific for Kv channels) which
can result in a variety of different pharmacological and
biophysical channel properties [42], it is possible that
changes in β subunit and/or accessory protein expression
could produce reductions in Kv4.3 channel function in
pregnant myometrium without any changes in channel
expression, and this could explain the difference in 4-AP
and Kv4.3 time courses in pregnant myometrium. It is,
however, also possible that fully-functional Kv4.3 chan-
nels are expressed in pregnant myometrial cells but are
not present in sufficient amounts in the plasma mem-
brane (e.g. they may be internalized to intracellular
domains), rendering them insensitive to blockade by 4-AP
and phrixotoxin-2.
Conclusion
We have uncovered a significant difference in responsive-
ness to the Kv channel blockers 4-AP and phrixotoxin-2
between nonpregnant and pregnant mouse myometrium,
and provide evidence for the expression of a number of Kv
channel α subunit proteins in myometrium from both
pregnant and nonpregnant mice; we also provide evi-
dence of a profound reduction in Kv4.3 α subunit expres-
sion in term-pregnant mouse myometrium. Taken
together these findings suggest a role for Kv channels inReproductive Biology and Endocrinology 2007, 5:41 http://www.rbej.com/content/5/1/41
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the regulation of uterine contractions, as well as a possible
molecular basis for the functional changes which occur in
the pregnant myometrium.
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